19 hours ago Aegis Sciences Corporation is a national leader in healthcare and forensic laboratory sciences. We leverage innovative technology and best practices to deliver the insight and answers for healthcare providers, sports organizations, and employers. >> Go To The Portal
Aegis Sciences Corporation is a national leader in healthcare and forensic laboratory sciences. We leverage innovative technology and best practices to deliver the insight and answers for healthcare providers, sports organizations, and employers.
12/21/21- In response to the ongoing COVID-19 pandemic, Aegis Sciences Corporation and Walgreens have collaborated to make real-time reverse transcriptase polymerase chain reaction (RT-PCR) testing readily available at more than 5,200 of the over 7,200 Walgreens locations that provide COVID-19 testing. As the virus that causes COVID-19 continues to mutate, both …
About Aegis. Founded in 1990, Aegis Sciences Corporation is a forensic toxicology and healthcare laboratory that provides science-driven drug testing and consulting services based in Nashville, TN. Aegis delivers evidence-based, clinically actionable information related to medication compliance, substance abuse, and drug-drug interactions ...
Founded in 1990, Aegis Sciences Corporation is a forensic toxicology and healthcare laboratory that provides science-driven drug testing and consulting services based in Nashville, TN.
Founded in 1990, Aegis Sciences Corporation is a forensic toxicology and healthcare laboratory that provides science-driven drug testing and consulting services based in Nashville, TN.
Aegis provides clarity for enhanced patient care to a wide array of clinicians that serve Medicare, Managed Medicaid, Commercially Insured and Workers' compensation population s. In addition to healthcare testing services, Aegis offers anti-doping and forensic testing services to professional and amateur sports organizations, ...
Founded in 1990, Aegis Sciences Corporation is a forensic toxicology and healthcare laboratory that provides science-driven drug testing and consulting services based in Nashville, TN. Aegis delivers evidence-based, clinically actionable information related to medication compliance, substance abuse, and drug-drug interactions through definitive testing of urine, oral fluid, or blood specimens. Aegis healthcare testing services are designed for the unique needs of healthcare specialties in the areas of Pain Management, Behavioral and Mental Health, Substance Use Disorder, Prenatal and Chronic Disease Management. Aegis provides clarity for enhanced patient care to a wide array of clinicians that serve Medicare, Managed Medicaid, Commercially Insured and Workers' compensation populations. In addition to healthcare testing services, Aegis offers anti-doping and forensic testing services to professional and amateur sports organizations, college and university athletic programs. Aegis’s biopharma lab provides molecular diagnostic services, including clinical trial services, pharmacogenetic testing, and other services. For more information please visit http://www.aegislabs.com/.
The DEA 2020 Emerging Threat Report ( https://lnkd.in/dMvtCCK) noted an ~157% increase in identifications of designer benzodiazepines in 2020 compared to 2019. Of novel psychoactive substances (NPS), the designer benzodiazepine class of NPS showed the greatest percent increase in identifications from 2019 to 2020 with flualprazolam and etizolam representing ~81% of identifications. Flualprazolam has been identified in illicit counterfeit alprazolam pills and been involved in overdose deaths across the country. The use of NPS will go undetected when providers only test for traditional drug class panels. Aegis offers industry-leading testing options for multiple classes of NPS including designer benzodiazepines. Learn more now: https://lnkd.in/d5jzjAF
Metonitazene, a designer opioid that drew public health concern beginning last year, has demonstrated the ability to contribute to overdose death, mentioned here: https://lnkd.in/dcYbuhc , by itself and in combination with other illicit compounds. Aegis offers healthcare providers the ability to test for metonitazene, along with other designer opioids, in urine samples, affording them the opportunity to mitigate the risk of adverse events such as overdoses. Learn more here: https://lnkd.in/d5jzjAF